Granisetron

Modify Date: 2024-01-02 20:49:34

Granisetron Structure
Granisetron structure
Common Name Granisetron
CAS Number 109889-09-0 Molecular Weight 312.41
Density 1.3±0.1 g/cm3 Boiling Point 532.0±40.0 °C at 760 mmHg
Molecular Formula C18H24N4O Melting Point N/A
MSDS N/A Flash Point 275.6±27.3 °C

 Use of Granisetron


Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy.IC50 Value: 17uM (GR reduced 5-HT-evoked contractions) [1]Target: 5-HT3 receptorin vitro: In rat forestomach GR reduced 5-HT-evoked contractions at IC50 17 /- 6 uM. In isolated rabbit heart, GR 0.003-0.03 nM dose-dependently reduced s-HT tachycardia; at high levels GR reduced submaximal and maximal responses to 5-HT [1].in vivo: Leukocyte accumulation was dose-dependently inhibited by granisetron both at 6 and 72 h after induction of inflammation. Granisetron increased PGE(2) level at a lower dose (50 microg/pouch) but higher doses (100 and 200 microg/pouch) inhibited the release. At the same time, TNFalpha production was decreased by the lower dose and increased by higher doses of granisetron in a reciprocal fashion [2]. The GTDS displayed non-inferiority to oral granisetron: complete control was achieved by 60% of patients in the GTDS group, and 65% in the oral granisetron group (treatment difference, -5%; 95% confidence interval, -13-3). Both treatments were well tolerated, the most common adverse event being constipation [3].Clinical trial: Effect of External Heat on a Transdermal Granisetron Patch in Pharmacokinetics (PK) of Healthy Subjects. Phase 1

 Names

Name granisetron
Synonym More Synonyms

 Granisetron Biological Activity

Description Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy.IC50 Value: 17uM (GR reduced 5-HT-evoked contractions) [1]Target: 5-HT3 receptorin vitro: In rat forestomach GR reduced 5-HT-evoked contractions at IC50 17 /- 6 uM. In isolated rabbit heart, GR 0.003-0.03 nM dose-dependently reduced s-HT tachycardia; at high levels GR reduced submaximal and maximal responses to 5-HT [1].in vivo: Leukocyte accumulation was dose-dependently inhibited by granisetron both at 6 and 72 h after induction of inflammation. Granisetron increased PGE(2) level at a lower dose (50 microg/pouch) but higher doses (100 and 200 microg/pouch) inhibited the release. At the same time, TNFalpha production was decreased by the lower dose and increased by higher doses of granisetron in a reciprocal fashion [2]. The GTDS displayed non-inferiority to oral granisetron: complete control was achieved by 60% of patients in the GTDS group, and 65% in the oral granisetron group (treatment difference, -5%; 95% confidence interval, -13-3). Both treatments were well tolerated, the most common adverse event being constipation [3].Clinical trial: Effect of External Heat on a Transdermal Granisetron Patch in Pharmacokinetics (PK) of Healthy Subjects. Phase 1
Related Catalog
References

[1]. Sanger GJ, Nelson DR. Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron). Eur J Pharmacol. 1989 Jan 10;159(2):113-24.

[2]. Maleki-Dizaji N, Eteraf-Oskouei T, Fakhrjou A, The effects of 5HT3 receptor antagonist granisetron on inflammatory parameters and angiogenesis in the air-pouch model of inflammation. Int Immunopharmacol. 2010 Sep;10(9):1010-6.

[3]. Boccia RV, Gordan LN, Clark G, Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study. Support Care Cancer. 2011 Oct;19(10):1609-17.

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Boiling Point 532.0±40.0 °C at 760 mmHg
Molecular Formula C18H24N4O
Molecular Weight 312.41
Flash Point 275.6±27.3 °C
PSA 50.16000
LogP 1.47
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.690
Storage condition -20℃

 Safety Information

HS Code 2934999090

 Synthetic Route

~%

Granisetron Structure

Granisetron

CAS#:109889-09-0

Literature: Journal of Medicinal Chemistry, , vol. 33, # 7 p. 1924 - 1929

~%

Granisetron Structure

Granisetron

CAS#:109889-09-0

Literature: Journal of Medicinal Chemistry, , vol. 33, # 7 p. 1924 - 1929

~%

Granisetron Structure

Granisetron

CAS#:109889-09-0

Literature: US2008/242696 A1, ; Page/Page column 3 ;

 Customs

HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Synonyms

1-(H)Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide
Kevatril
BIDD:GT0272
Sancuso
[3H]-Granisetron
UNII-WZG3J2MCOL
1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide
HMS2089P14
granisetron hydrochloride
1H-Indazole-3-carboxamide, 1-(methyl-d)-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-
Top Suppliers:I want be here



Get all suppliers and price by the below link:

Granisetron suppliers


Price: $84/50mg

Reference only. check more Granisetron price